Literature DB >> 1750167

Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters.

A C Jackson1, S K SenGupta, J F Smith.   

Abstract

The pathogenesis of Venezuelan equine encephalitis (VEE) virus infection was compared in intraperitoneally inoculated mice (n = 24, 6 to 8 weeks old) and hamsters (n = 9, 90-110 g) using histopathology and immunohistochemical localization of VEE virus antigen. Infected mice developed paralysis, and the majority died by 9 days after inoculation. In contrast, hamsters did not survive beyond 3 days after inoculation, and they did not develop any neurologic signs. VEE virus antigen, demonstrated by immunoperoxidase staining, and pathologic changes were present in extraneural organs of both mice and hamsters. There was more severe involvement in hamsters, particularly in Peyer's patches of the distal small intestine. There was a severe encephalomyelitis in mice, but pathologic changes were not well established in the brains of hamsters before death. VEE virus antigen was widespread in the central nervous system of both mice and hamsters. VEE virus was found to be highly neurotropic in hamsters and had a similar distribution in the brain as in mice, but hamsters died from their extraneural disease before major central nervous system disease developed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750167     DOI: 10.1177/030098589102800509

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  25 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors.

Authors:  Sarah M Richardson-Burns; Douglas J Kominsky; Kenneth L Tyler
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

3.  Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.

Authors:  G H MacDonald; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.

Authors:  Ann R Hunt; Richard A Bowen; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  Virology       Date:  2011-04-13       Impact factor: 3.616

5.  A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.

Authors:  N L Davis; K W Brown; R E Johnston
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

Authors:  Janice M Rusnak; Lesley C Dupuy; Nancy A Niemuth; Andrew M Glenn; Lucy A Ward
Journal:  Comp Med       Date:  2018-10-03       Impact factor: 0.982

Review 7.  Vaccines for Venezuelan equine encephalitis.

Authors:  Slobodan Paessler; Scott C Weaver
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

8.  Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.

Authors:  Slobodan Paessler; Rafik Z Fayzulin; Michael Anishchenko; Ivorlyne P Greene; Scott C Weaver; Ilya Frolov
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence.

Authors:  Patricia V Aguilar; A Paige Adams; Eryu Wang; Wenli Kang; Anne-Sophie Carrara; Michael Anishchenko; Ilya Frolov; Scott C Weaver
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs.

Authors:  Chad J Roy; Douglas S Reed; Catherine L Wilhelmsen; Justin Hartings; Sarah Norris; Keith E Steele
Journal:  Virol J       Date:  2009-10-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.